1438984-03-2

Basic information

• Product Name: (S)-N-((S)-1-(4-bromophenyl)ethyl)-2-methylpropane-2-sulfinamide
• Synonyms: (S)-N-((S)-1-(4-bromophenyl)ethyl)-2-methylpropane-2-sulfinamide
• CAS NO: 1438984-03-2
• Molecular Weight: 304.251
• Mol File: 1438984-03-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (S)-N-((S)-1-(4-bromophenyl)ethyl)-2-methylpropane-2-sulfinamide(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-N-((S)-1-(4-bromophenyl)ethyl)-2-methylpropane-2-sulfinamide(1438984-03-2)
• EPA Substance Registry System: (S)-N-((S)-1-(4-bromophenyl)ethyl)-2-methylpropane-2-sulfinamide(1438984-03-2)

Safety Data

• Hazardous Substances Data: 1438984-03-2(Hazardous Substances Data)

Upstream product

• 99-90-1 para-bromoacetophenone 
• 1039750-63-4 (S,E)-N-(1-(4-bromophenyl)ethylidene)-2-methylpropane-2-sulfinamide 

Downstream Products

• 84499-77-4 (S)-α-(p-bromophenyl)ethylamine hydrochloride 

Relevant articles and documents

N-BENZYLBENZIMIDAZOLE MODULATORS OF PPARG

The invention provides molecular entities that bind with high affinity to PPARG (PPAR?), inhibit cdk5-mediated phosphorylation of PPARG, but do not exert an agonistic effect on PPARG. Compounds of the invention can be used for treatment of conditions in patients wherein PPARG plays a role, such as diabetes or obesity. Methods of preparation of the compounds, bioassay methods for evaluating compounds of the invention as non-agonistic PPARG binding compounds, and pharmaceutical compositions are also provided.